REVER3BAB: AN INNOVATIVE BIOLOGICAL MEDICINE FOR REVERTIRE THE RESISTANCE TO CONVENTIONAL CANCER TREATMENT (Q2035362): Difference between revisions
Jump to navigation
Jump to search
(Removed claim: financed by (P890): Directorate-General for Regional and Urban Policy (Q8361), Removing unnecessary financed by statement) |
(Changed label, description and/or aliases in fr, and other parts: Adding French translations) |
||||||||||||||
| label / fr | label / fr | ||||||||||||||
REVER3MAB: UN MÉDICAMENT BIOLOGIQUE INNOVANT POUR REVENIR À LA RÉSISTANCE AUX THÉRAPIES ONCOLOGIQUES CONVENTIONNELLES | |||||||||||||||
| Property / summary | |||||||||||||||
REVER3MAB: UN ANTICORPS MONOCLONAL DIRIGÉ CONTRE LA PROTÉINE ERBB3 QUI PEUT BLOQUER LA PROLIFÉRATION DES CELLULES TUMORALES IN VITRO ET IN VIVO, AVEC UNE UTILISATION POTENTIELLE COMME AGENT THÉRAPEUTIQUE EN CLINIQUE. (French) | |||||||||||||||
| Property / summary: REVER3MAB: UN ANTICORPS MONOCLONAL DIRIGÉ CONTRE LA PROTÉINE ERBB3 QUI PEUT BLOQUER LA PROLIFÉRATION DES CELLULES TUMORALES IN VITRO ET IN VIVO, AVEC UNE UTILISATION POTENTIELLE COMME AGENT THÉRAPEUTIQUE EN CLINIQUE. (French) / rank | |||||||||||||||
Normal rank | |||||||||||||||
| Property / summary: REVER3MAB: UN ANTICORPS MONOCLONAL DIRIGÉ CONTRE LA PROTÉINE ERBB3 QUI PEUT BLOQUER LA PROLIFÉRATION DES CELLULES TUMORALES IN VITRO ET IN VIVO, AVEC UNE UTILISATION POTENTIELLE COMME AGENT THÉRAPEUTIQUE EN CLINIQUE. (French) / qualifier | |||||||||||||||
point in time: 16 December 2021
| |||||||||||||||
Revision as of 08:07, 16 December 2021
Project Q2035362 in Italy
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | REVER3BAB: AN INNOVATIVE BIOLOGICAL MEDICINE FOR REVERTIRE THE RESISTANCE TO CONVENTIONAL CANCER TREATMENT |
Project Q2035362 in Italy |
Statements
423,871.16 Euro
0 references
847,742.32 Euro
0 references
50.0 percent
0 references
13 December 2016
0 references
6 July 2019
0 references
ISTITUTI FISIOTERAPICI OSPITALIERI - IFO
0 references
TAKIS SRL
0 references
ISTITUTO BIOCHIMICO ITALIANO G. LORENZINI
0 references
41°53'35.95"N, 12°28'58.55"E
0 references
REVER3MAB: UN ANTICORPO MONOCLONALE DIRETTO CONTRO LA PROTEINA ERBB3 IN GRADO DI BLOCCARE LA PROLIFERAZIONE DELLE CELLULE TUMORALI IN VITRO E IN VIVO, CON POTENZIALE USO COME AGENTE TERAPEUTICO IN CLINICA. (Italian)
0 references
REVER3BAB: A MONOCLONAL ANTIBODY AGAINST THE ERBB3 PROTEIN CAPABLE OF BLOCKING IN VITRO AND IN VIVO CANCER CELLS, WITH POTENTIAL USE AS A THERAPEUTIC AGENT IN CLINICAL USE. (English)
0 references
REVER3MAB: UN ANTICORPS MONOCLONAL DIRIGÉ CONTRE LA PROTÉINE ERBB3 QUI PEUT BLOQUER LA PROLIFÉRATION DES CELLULES TUMORALES IN VITRO ET IN VIVO, AVEC UNE UTILISATION POTENTIELLE COMME AGENT THÉRAPEUTIQUE EN CLINIQUE. (French)
16 December 2021
0 references
Identifiers
F87H18000370007
0 references